SEARCH NEWS & VIEWS


Scientists Uncover New, Fundamental Mechanism for How Resveratrol Provides Health Benefits
Researchers Find Drug That Helps Huntington’s Disease-Afflicted Mice—and Their Offspring
Team Illuminates Mysterious Molecular Mechanism Powering Cells in Most Forms of Life
New Hope for Newborns: How a TSRI Scientist Brought a Life-Saving Drug from the Lab to the Clinic
NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT

FOLLOW US

Of Note


Ryan Shenvi Receives Novartis Early Career Award, BMS Grant

Ryan Shenvi, associate professor at The Scripps Research Institute (TSRI), has received a Novartis Early Career Award, a distinction recognizing outstanding scientists establishing careers in the areas of organic or bioorganic chemistry. With the award, Shenvi, one of two honorees worldwide, receives an unrestricted grant from the award’s sponsor, Novartis, a multinational pharmaceutical company based in Switzerland. Shenvi and co-honoree Daniel Weix of the University of Rochester will travel to Basel, Switzerland to deliver back-to-back lectures.

The Shenvi lab also recently won an unrestricted grant in synthetic organic chemistry from Bristol-Myers Squibb (BMS), a global biopharmaceutical company headquartered in New York City. Shenvi will deliver a lecture at BMS in the spring.

Research in the Shenvi lab focuses on complex molecule synthesis, exploration of chemical reactivity and expansion of the tools available to synthetic chemists.


Fabian Stavenuiter Awarded Travel Grant

Fabian Stavenuiter, research associate in the Mosnier lab, received a travel award from ACEA Biosciences (ACEA) to present a poster at the recent 56th American Society of Hematology annual meeting in San Francisco. His presentation was titled “Non-Canonical PAR3 Activation Induces Tie2-Dependent Endotelial Barrier Protective Effects.” The ACEA travel grants are awarded quarterly to researchers whose conference presentations utilize ACEA technologies.

Stavenuiter’s research focuses on protease activated receptors, primarily PAR3 and PAR1, that might improve therapies in ischemic stroke and sepsis.


TSRI Presents 26th Frontiers in Chemistry Symposium

TSRI’s 26th Annual Frontiers in Chemistry Symposium will feature four distinguished speakers covering diverse topics in the molecular sciences on Friday, January 30, from 1 to 5:15 PM.

"We are especially pleased to present our 26th Frontiers in Chemistry symposium not only for Scripps, but also for the San Diego community,” said Dale Boger, chair of the TSRI’s Department of Chemistry and symposium co-host with TSRI Professor Phil Baran. “We have a wonderful set of speakers who will help us celebrate more than 25 years of chemistry at Scripps.” 

Symposium speakers and their lectures are:

  • JoAnne Stubbe, Novartis Professor of Chemistry & Biology at the Massachusetts Institute of Technology and National Medal of Science winner, speaking on “Radicals: Your Life Is in Their Hands.”
  • Chad Mirkin, director of the International Institute for Nanotechnology, the George B. Rathmann Professor of Chemistry at Northwestern University and Linus Pauling Medal winner, speaking on “Spherical Nucleic Acids as Intracellular Gene Regulation Agents.”
  • Laura Kiessling, Steenbock Professor of Chemistry and director of the Keck Center for Chemical Genomics at the University of Wisconsin and Arthur C. Cope Scholar Award winner, speaking on “Us Versus Them: Distinguishing Human and Microbial Cells.”
  • Chi-Huey Wong, professor of chemistry at TSRI, winner of the Wolf Prize in Chemistry and the Arthur C. Cope Award and president of Academia Sinica in Taiwan, speaking on “Chemistry and Biology of Glycosylation.”

Open to the public, the symposium provides an opportunity for TSRI faculty, postdoctoral fellows, graduate students and neighboring scientists to hear from some of the world’s best researchers. Since it began in 1989, the symposium has hosted 88 speakers, including 13 Nobel laureates.

Symposium sponsors include AbbVie, Abide Therapeutics, ActivX, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Genomics Institute of the Novartis Research Foundation, Janssen, Lilly, Merck, Pfizer, Sigma Aldrich, Vertex and WuXi AppTec.

While symposium admittance is free, attendance is limited to 300. Directions to the event, which will be held at The Auditorium at TSRI, and parking details are available at the symposium website or by contacting Janise Petrey at jpetrey@scripps.edu or (858) 784-8772. 





Send comments to: mikaono[at]scripps.edu

shenvi
Chemist Ryan Shenvi has won awards from Novartis and Brystol-Myers Squibb. (Photo by BioMedical Graphics.)